|
TKC145596
|
MCF7 |
|
85.0 |
% |
Activity |
C4194 |
|
|
TKC145596
|
HEp-2 |
Hep-2; HEP-2; Hep2 (HeLa derivative); HEp-2/HeLa; Hep 2; Hep2; HEp2; HEP2; H.Ep.-2; H.Ep. #2; H.Ep. No. 2; Hep II; Human Epidermoid carcinoma #2; Human Epithelioma-2 |
105700.0 |
nM |
IC50 |
C27677 |
|
|
TKC145596
|
Caco-2 |
CaCo-2; CACO-2; Caco 2; CACO 2; CACO2; CaCo2; CaCO2; Caco2; Caco-2/ATCC; Caco-II |
104100.0 |
nM |
IC50 |
C4349 |
|
|
TKC145596
|
A549 |
|
95580.0 |
nM |
IC50 |
C3512 |
|
|
TKC145596
|
K562 |
K562; K.562; K 562; KO; GM05372; GM05372E |
76710.0 |
nM |
IC50 |
C9110 |
Orphanet_521 |
|
TKC145596
|
C8166 |
C8166-CD4 |
20.0 |
ug ml-1 |
TC50 |
|
|
|
TKC145596
|
NCI-H460 |
NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 |
104.0 |
% |
Activity |
C4450 |
|
|
TKC145596
|
HT-29 |
HT 29; HT29 |
85.0 |
% |
Activity |
C4349 |
|
|
TKC145596
|
CCRF-CEM |
CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C |
89.0 |
% |
Activity |
C7953 |
Orphanet_99861 |
